Search results for "Menor"

showing 10 items of 179 documents

La conducta delictiva del menor en el estado de Jalisco (México). Análisis diferencial de factores psicosociales asociados como el consumo de drogas

2007

El principal objetivo de este estudio es analizar las características diferenciales de la socialización familiar de menores primarios y reincidentes que infringen las leyes en el estado de Jalisco (México), tratando de describir la estructura y organización familiar, el nivel de convivencia, la carrera delictiva en la familia de origen, los estilos parentales o la experimentación propia y modelado paterno con drogas, entre otros indicadores. Para realizar un análisis diferencial de los perfiles se ha seleccionado un grupo de 342 estudiantes de secundaria pública no infractores y otro de 359 menores infractores retenidos e institucionalizados del Centro de Atención al Menor Infractor en Tlaq…

:PSICOLOGÍA::Psicofarmacología [UNESCO]Menor conducta delictiva socialización paterna consumo de drogas.:PSICOLOGÍA [UNESCO]UNESCO::PSICOLOGÍAUNESCO::PSICOLOGÍA::Psicofarmacología
researchProduct

Menores en situación de calle: la doble vulnerabilidad hacia el consumo de drogas

2003

Aventurarse a conocer algunos de los asuntos que envuelven la cotidianeidad de los menores en situación de calle, implica tratar de comprender complejos procesos sociales y estructurales que llevan a estos niños y niñas a convertir a la calle y a otros espacios públicos en su lugar de residencia, así como los motivos que tienen para permanecer en ella. El consumo de drogas en esta población, particularmente en aquella que no mantiene o carece de vínculos familiares, se convierte en una actividad casi generalizada y, dada la situación extraordinaria en que se encuentran, su atención requiere de intervenciones muy específicas e instrumentadas desde posiciones muy sensibilizadas hacia la neces…

:PSICOLOGÍA::Psicofarmacología [UNESCO]Menores en situación de calle drogas intervención:PSICOLOGÍA [UNESCO]UNESCO::PSICOLOGÍAUNESCO::PSICOLOGÍA::Psicofarmacología
researchProduct

Does Preoperative Treatment with a Gonadotropin-Releasing Hormone Agonist Improve the Outcome of Endometrial Resection?

1998

Abstract Study Objective. To verify if more favorable long-term results of endometrial resection can be obtained with preoperative gonadotropin-releasing hormone (GnRH) agonist treatment. Design. Multicenter, randomized, controlled trial (Canadian Task Force classification I). Setting. Tertiary care academic department. Patients. Sixty-three premenopausal women with established menorrhagia. Intervention. Eight weeks of goserelin depot treatment before endometrial resection or immediate surgery in the early proliferative phase of the cycle. Measurements and Main Results. Variations in menstrual patterns and bleeding scores as well as overall degree of satisfaction with treatment were determi…

AdultAgonistmedicine.medical_specialtyAntineoplastic Agents Hormonalmedicine.drug_classlaw.inventionEndometriumRandomized controlled triallawGonadotropin-releasing hormone agonistPreoperative CareFollicular phaseElectrocoagulationmedicineHumansProspective StudiesMenorrhagiabusiness.industryGoserelinObstetrics and GynecologyEndoscopyMiddle AgedSurgeryExact testTreatment OutcomeDelayed-Action PreparationsUterine NeoplasmsGoserelinFemaleAmenorrheamedicine.symptombusinessAdenomyomamedicine.drugHormone
researchProduct

Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of th…

2016

Functional hypothalamic amenorrhea is a disorder characterized by cessation of menstrual cycles in the absence of organic disease. In most patients, it occurs in adult life after a stressful event and may be related to a condition of mild chronic energy deprivation. The endocrine pattern is characterized by low estrogen levels with an absent response to a progestogen challenge test and low-normal gonadotropin levels. A few studies have shown that some of these women may have some features of polycystic ovary syndrome; these features include an increased androgen response to gonadotropins, increased anti-Mullerian hormone levels, and altered ovarian morphology or increased ovarian size. Thes…

AdultAnti-Mullerian Hormoneendocrine systemmedicine.medical_specialtyendocrine system diseases030209 endocrinology & metabolismOvaryOrganic diseaseHypothalamic disease03 medical and health sciencesFollicle-stimulating hormoneYoung Adult0302 clinical medicineInternal medicinemedicineHumansTestosteroneAmenorrheaRetrospective Studies030219 obstetrics & reproductive medicinebiologybusiness.industryOvaryAndrostenedioneObstetrics and GynecologyAnti-Müllerian hormoneDehydroepiandrosteroneOrgan SizeLuteinizing Hormonemedicine.diseasePolycystic ovaryEndocrinologymedicine.anatomical_structureCase-Control Studiesbiology.proteinAmenorrheaFemalemedicine.symptomFollicle Stimulating HormoneLuteinizing hormonebusinessHypothalamic DiseasesPolycystic Ovary SyndromeAmerican journal of obstetrics and gynecology
researchProduct

Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual func…

2017

Since features of polycystic ovary syndrome (PCOS) have been found to be prevalent in women with functional hypothalamic amenorrhea (FHA), we wished to determine what happens to these features after recovery of menstrual function in FHA Design: Prospective cohort study. Twenty-eight women with FHA and 30 age-matched ovulatory controls were studied.Twenty-eight women with FHA and 30 age-matched ovulatory controls were studied. We measured serum estradiol, LH, FSH, testosterone, DHEAS, anti-Mullerian hormone (AMH), body mass index, and ovarian morphology on transvaginal ultrasound.At baseline, 12 of the 28 women (43%) had increased AMH (4.7 ng/mL), and higher testosterone and larger ovaries c…

AdultAnti-Mullerian Hormoneendocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismHypothalamic amenorrheaYoung Adult03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicinemedicineHumansTestosteroneProspective StudiesAmenorrheaUltrasonography030219 obstetrics & reproductive medicineEstradiolDehydroepiandrosterone Sulfatebusiness.industryPolycystic ovary syndrome (PCOS)OvaryObstetrics and GynecologyTestosterone (patch)Luteinizing Hormonemedicine.diseasePolycystic ovaryhumanitiesMenstruationEndocrinologyOvarian morphologyFemaleFollicle Stimulating HormonebusinessHypothalamic DiseasesPolycystic Ovary SyndromeGynecological Endocrinology
researchProduct

The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome

2007

BACKGROUND: Insulin glargine is a once-daily basal insulin analog with prolonged duration of action and absence of an evident peak. Glargine is associated with reduced frequency of hypoglycemic episodes (mostly nocturnal) as well as effective glycemic control. Maintenance of good metabolic control before conception and throughout pregnancy is essential to lower the risk of fetal malformations. Glargine might be a valuable alternative in the management of pregnancies complicated by diabetes mellitus. However, because its clinical utility has not been established, the use of glargine is not currently recommended during pregnancy. OBJECTIVE: The aim of this study was to retrospectively evaluat…

AdultHirsutismmedicine.medical_specialtyAdolescentendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentModels BiologicalSensitivity and SpecificitySettore MED/13 - EndocrinologiaYoung Adultchemistry.chemical_compoundEndocrinologyInternal medicineAcne VulgarismedicineHumansOutpatient clinicpcos insulin sensitivityRetrospective StudiesMetabolic SyndromeC-peptidebusiness.industryInsulinHyperandrogenismCase-control studynutritional and metabolic diseasesRetrospective cohort studymedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsOligomenorrheaEndocrinologychemistryCase-Control StudiesFemaleInsulin ResistanceMetabolic syndromeHyperandrogenismbusinessPolycystic Ovary SyndromeClinical Endocrinology
researchProduct

Bone Mineral Density and Long Term Exercise

1993

Evidence in human studies of the association of long term habitual exercise with bone mineral content (BMC) and density (BMD) largely comes from studies in athletes. In young adults, the highest BMC and BMD values have been found in strength and power-trained athletes, while endurance activities such as long distance running and swimming seem less effective with regard to peak bone density. Intensive endurance training may even be associated with amenorrhoea and decreased trabecular bone density in young females. However, after menopause female athletes show greater bone mass indicating that they do not share the accelerated decline in BMC observed in a nonathletic population. Middle-aged a…

AdultMalemusculoskeletal diseasesmedicine.medical_specialtyBone densitySports medicinePopulationPhysical Therapy Sports Therapy and RehabilitationPhysical exerciseRunningBone DensityEndurance trainingmedicineHumansOrthopedics and Sports MedicineeducationAmenorrheaExerciseSwimmingAgedBone mineraleducation.field_of_studybiologyAthletesbusiness.industrymusculoskeletal neural and ocular physiologyMiddle Agedmusculoskeletal systembiology.organism_classificationmedicine.diseasehumanitiesMenopauseCross-Sectional StudiesPhysical therapyFemaleMenopausebusinessSportsSports Medicine
researchProduct

Eutopic endometrium from women with endometriosis does not exhibit neurotrophic properties

2012

The role of neurotrophins in eutopic endometrium from endometriosis-patients was investigated in a prospective study using immunofluorescence-staining, Western blot and a neuronal growth assay. The nerve growth factor is expressed in primary endometrial cell culture from women with and without endometriosis. Western blot analysis of endometrial biopsies or uterine fluid from patients with and without endometriosis shows no difference in the neurotrophin expression. We could not find a difference between patients with and without endometriosis with regards to the neurite outgrowth of sensory ganglia when treated with conditioned cultured medium or uterine fluid. This result refutes the assum…

AdultPathologymedicine.medical_specialtyNeuriteBlotting WesternImmunologyEndometriosisEndometriosisFluorescent Antibody TechniqueNeuriteEndometrial innervationAndrologyYoung AdultEndometrial innervation; Endometriosis; Pelvic painPelvic painWestern blotNeurotrophic propertieNerve Growth FactorNeuritesmedicineHumansImmunology and AllergyEutopic endometriumEndometriosiProspective cohort studyUterine Diseasesbiologymedicine.diagnostic_testbusiness.industryPelvic painDysmenorrhoeaMiddle Agedmedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaNerve growth factorNeurologyCulture Media Conditionedbiology.proteinUterine DiseaseFemaleNeurology (clinical)medicine.symptombusinessNeurotrophinHuman
researchProduct

Vesico-uterine fistula treated by amenorrhoea induced with contraceptive steroids. Two case reports.

1980

2 case reports of women with vesico-uterine fistulae who were successfully treated by inducing amenorrhea by the continuous administration of an estrogen-progestogen compound for 6 months are presented. Ortho-Novum 1/50 was used. The amenorrheic condition induced by continuous ingestion of an oral contraceptive agent allowed the fistula time to heal since fistulae rarely close spontaneously because of fluids flowing fhrough them inhibiting the healing process. This method of management should be tried before surgery the generally recommended treatment.

AdultUterine Diseasesmedicine.medical_specialtyFistulabusiness.industryUrinary Bladder FistulaResearch methodologyFistulaObstetrics and GynecologyUterine Fistulamedicine.diseaseOral contraceptive agentSurgeryContraceptives Oral CombinedFamily planningmedicineHumansAmenorrheaFemalemedicine.symptombusinessAmenorrheaContraceptives OralBritish journal of obstetrics and gynaecology
researchProduct

A first-in-human study of PDC31 (prostaglandin F2  receptor inhibitor) in primary dysmenorrhea

2014

What is the safe and pharmacodynamically active dose range for PDC31 (prostaglandin F2α receptor inhibitor) in patients with primary dysmenorrhea (PD)?The 1 mg/kg/h dose of PDC31 appears to be safe and potentially effective in reducing intrauterine pressure (IUP) and pain associated with excessive uterine contractility when given as a 3-h infusion in patients with PD.PDC31 has previously been shown to reduce the duration and strength of PGF2α-induced contractions in human uterine myometrial strip models and to delay delivery in animal models of preterm labor.This was a prospective, multi-center, dose-escalating first-in-human Phase I study conducted from March 2011 to June 2012. A total of …

AdultVisual analogue scaleUterusPlaceboDrug Administration ScheduleUterine contractionYoung AdultDysmenorrheaPharmacokineticsInfusion ProceduremedicineHumansProspective StudiesAdverse effectDose-Response Relationship Drugbusiness.industryRehabilitationObstetrics and GynecologyTreatment Outcomemedicine.anatomical_structureReproductive MedicineAnesthesiaPharmacodynamicsFemalemedicine.symptomPeptidesbusinessHuman Reproduction
researchProduct